San Diego, January 14, 2026
Illumina Inc., based in San Diego, has unveiled a vast cell atlas designed to accelerate drug discovery. This resource provides researchers with critical insights into cellular structures and functions, thereby enhancing the development of new therapeutics. With advanced sequencing technology and comprehensive data on various cell types, the atlas simplifies complex data access for researchers, paving the way for quicker identification of potential drug targets and more efficient treatment development.
San Diego, CA – Illumina Unveils Massive Cell Atlas to Accelerate Drug Discovery
Illumina Inc., a leading biotechnology company based in San Diego, has introduced a comprehensive cell atlas aimed at expediting drug discovery processes. This extensive resource provides detailed insights into cellular structures and functions, offering researchers valuable data to enhance the development of new therapeutics.
Key Features of the Cell Atlas
- Comprehensive Data: The atlas includes extensive information on various cell types, their interactions, and genetic expressions.
- Advanced Technology: Utilizes cutting-edge sequencing and imaging technologies to map cellular components with high precision.
- Accessibility: Designed to be user-friendly, allowing researchers to easily access and interpret complex data.
Implications for Drug Discovery
The release of this cell atlas is expected to significantly accelerate drug discovery by providing a deeper understanding of disease mechanisms at the cellular level. Researchers can now identify potential drug targets more efficiently, leading to faster development of effective treatments.
Background on Illumina Inc.
Founded in 1998 and headquartered in San Diego, Illumina Inc. specializes in next-generation sequencing and array-based solutions for genetic analysis. The company’s technologies are widely used in various fields, including genomics, oncology, and reproductive health, contributing to advancements in personalized medicine and diagnostics.
Stock Performance
As of January 14, 2026, Illumina’s stock (ticker: ILMN) is trading at $146.99, reflecting a slight increase of 0.95% from the previous close. The day’s trading saw a high of $151.11 and a low of $142.55, with an opening price of $150.00 and a volume of 2,298,204 shares.
Frequently Asked Questions (FAQ)
What is the purpose of Illumina’s new cell atlas?
The cell atlas aims to provide detailed insights into cellular structures and functions, offering researchers valuable data to enhance the development of new therapeutics.
How does the cell atlas impact drug discovery?
The release of this cell atlas is expected to significantly accelerate drug discovery by providing a deeper understanding of disease mechanisms at the cellular level, allowing researchers to identify potential drug targets more efficiently.
What technologies does Illumina use in the cell atlas?
Illumina utilizes cutting-edge sequencing and imaging technologies to map cellular components with high precision in the cell atlas.
When was Illumina Inc. founded?
Illumina Inc. was founded in 1998 and is headquartered in San Diego, California.
What is Illumina’s stock performance as of January 14, 2026?
As of January 14, 2026, Illumina’s stock (ticker: ILMN) is trading at $146.99, reflecting a slight increase of 0.95% from the previous close.
Key Features of Illumina’s Cell Atlas
| Feature | Description |
|---|---|
| Comprehensive Data | Includes extensive information on various cell types, their interactions, and genetic expressions. |
| Advanced Technology | Utilizes cutting-edge sequencing and imaging technologies to map cellular components with high precision. |
| Accessibility | Designed to be user-friendly, allowing researchers to easily access and interpret complex data. |
Deeper Dive: News & Info About This Topic
HERE Resources
Author: STAFF HERE SAN DIEGO WRITER
The SAN DIEGO STAFF WRITER represents the experienced team at HERESanDiego.com, your go-to source for actionable local news and information in San Diego, San Diego County, and beyond. Specializing in "news you can use," we cover essential topics like product reviews for personal and business needs, local business directories, politics, real estate trends, neighborhood insights, and state news affecting the area—with deep expertise drawn from years of dedicated reporting and strong community input, including local press releases and business updates. We deliver top reporting on high-value events such as Comic-Con International, San Diego County Fair, and San Diego Pride Festival. Our coverage extends to key organizations like the San Diego Regional Chamber of Commerce and United Way of San Diego County, plus leading businesses in biotechnology, healthcare, and technology that power the local economy such as Qualcomm, Illumina, and Scripps Health. As part of the broader HERE network, including HEREAnaheim.com, HEREBeverlyHills.com, HERECostaMesa.com, HERECoronado.com, HEREHollywood.com, HEREHuntingtonBeach.com, HERELongBeach.com, HERELosAngeles.com, HEREMissionViejo.com, and HERESantaAna.com, we provide comprehensive, credible insights into California's dynamic landscape.
